VIRALEZE antiviral nasal spray is a product manufactured by Starpharma Biotechnology Company, based in Melbourne, Australia. The product has been issued by the Ministry of Health with the file code 000.00.19 H26-211119. 0007 publication number 210002011/PCBA-HN publication date 30/11/2021.
Attending the press conference were representatives of the media – Mr. Tran Quoc Viet, Editor-in-Chief of the People’s Court Magazine; Ms. Nguyen Thu Trang, Director of TAF Medical Company. Also attending were representatives of the Traffic Newspaper, the Public Health Magazine, which sponsored the media, and many reporters of the media agencies.
Speaking at the press conference, Mr. Tran Quoc Viet, Editor-in-Chief of the People’s Court Magazine, said that in the context of the entire Party and people, they are joining hands to fight the Covid-19 pandemic, overcoming the consequences of the pandemic. Because of this, the launch of a product to protect people’s health from the spread of the Covid-19 virus is an extremely practical and meaningful activity. Mineral nasal spray product is a compact, convenient product with proven effectiveness, which will definitely contribute to the prevention of Covid-19, bringing safety to users.
Mr. Tran Quoc Viet, Editor-in-Chief of TAND Magazine speaks at the press conference
The Covid-19 epidemic has been having unpredictable developments that are not easy to prevent, especially at the moment there are many new variants of the virus that cause concern that will create new outbreaks in this winter. . Therefore, in addition to complying with medical protection measures by 5K measures and vaccination, many well-known companies in the world have researched products to help health, prevent viruses, bring health benefits, and bring health benefits. opportunity to protect people’s safety from new attacks of life-threatening viruses
Representative of TAF MEDICAL Company Ms. Nguyen Thu Trang said that Australia’s Starpharma Biopharmaceutical Company has successfully researched and developed VIRALEZE Antiviral Nasal Spray that can fight Alpha, Beta and Gamma forms of Covid. -19. Data published by the manufacturer on June 18, 2021 shows that VIRALEZE Antiviral Nasal Spray is more than 99.99% effective against three out of four variants of the SARS-CoV-2 virus.
Representative of TAF MEDICAL company Ms. Nguyen Thu Trang speaks at the press conference
Analyzing the active ingredients contained in VIRALEZE, the Scripps Research Institute in the US said that SPL7013 contained in the Nasal Spray killed the virus within 30 seconds to a minute and achieved a reduction of more than 99% of the infectious virus compared to other products. Beta and Gamma variants, and over 99.9% within five minutes. For the Alpha variant, VIRALEZE Antiviral Nasal Spray reduced more than 99.99% of the virus within 30 seconds to one minute.
Protecting and promoting health is increasingly shown to be important in life as people are aware of protecting their own health and that of their families. Self-care will be considered as a globally integrated approach to people. This is also a goal promoted and supported by the World Health Organization – WHO.
Antiviral spray VIRALEZE has been officially announced and circulated in Vietnam from November 30, 2021, License Number Published 21000201/PCBA-HN.
This product not only provides a moisturizing protective barrier to the nasal mucosa, but can also be used for increased safety when needed, up to 4 times per day.
Representatives of importers, distributors, experts answer questions from the press
Dr. Jackie Fairley – CEO of StarPharma Holdings Company said online VIRALEZE has many special advantages that create a health protection barrier, useful for everyone’s health in gathering activities. crowded. VIRALEZE not only fights against Alpha, Beta, and Gamma variants of Covid-19 but also contributes to the safety of everyone against original virus strains from the US, Europe and Australia.
Many questions from reporters were answered convincingly by the Organizing Committee.
Source: Tòa Án Nhân Dân